Neurodegenerative disorders, metabolic icebergs, and mitohormesis

Area of Science:

• Neurobiology
• Mitochondrial Biology
• Metabolic Disorders

Background:

• Neurodegenerative disorders (Alzheimer's, Parkinson's, ALS, Huntington's) are traditionally classified by distinct clinical and pathological features.
• A unifying perspective suggests impaired mitochondrial biology as a common underlying pathology across these conditions.
• This shared feature can be conceptualized within a 'metabolic iceberg' framework.

Purpose of the Study:

• To present a scientific framework conceptualizing neurodegenerative diseases as 'metabolic icebergs'.
• To elucidate the interconnectedness of environmental, genetic, and mitochondrial factors in disease etiology.
• To propose mitohormesis as a therapeutic strategy for neurodegenerative disorders.

Main Methods:

• Conceptual framework development using the 'metabolic iceberg' model.
• Analysis of the interplay between environmental factors, genetics, and mitochondrial dysfunction.
• Identification of mitohormesis as a potential reparative mechanism.

Main Results:

• Neurodegenerative diseases are characterized by a visible 'tip' (symptoms, aggregates) and a hidden 'bulk' (impaired mitochondrial biology).
• The 'base' of the iceberg includes environmental toxins, lifestyle, and genetic factors contributing to mitochondrial dysfunction.
• Impaired mitochondrial biology progresses over time, leading to specific neurodegenerative phenotypes.

Conclusions:

• Impaired mitochondrial biology is a central, unifying feature of major neurodegenerative disorders.
• Mitohormesis, achieved through controlled stress and recovery, can potentially repair and recalibrate mitochondrial function.
• Harnessing mitohormesis presents a promising avenue for the prevention and treatment of neurodegenerative diseases.